Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century

Blood Cancer J. 2024 Mar 14;14(1):44. doi: 10.1038/s41408-024-01033-7.

Kari Hemminki^{1

2}, Frantisek Zitricky³, Asta Försti^{4

5}, Mika Kontro^{6

7

8}, Bjorn T Gjertsen^{9

10}, Marianne Tang Severinsen^{11

12}, Gunnar Juliusson^{13

14}

¹ Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic. K.Hemminki@dkfz.de.
² Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. K.Hemminki@dkfz.de.
³ Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic.
⁴ Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
⁵ Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
⁶ Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
⁷ Foundation for the Finnish Cancer Institute, Helsinki, Finland.
⁸ Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
⁹ Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.
¹⁰ Hematology Section, Department of Medicine, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway.
¹¹ Department of Hematology, Clinical Cancer Research Unit, Aalborg University Hospital, Aalborg, Denmark.
¹² Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
¹³ Department of Hematology, Skåne University Hospital, Lund, Sweden.
¹⁴ Department of HematologyStem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden.

No abstract available

Publication types